⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VALN News
Valneva SE American Depositary Shares
Valneva to Participate in Multiple Events at the 26th World Vaccine Congress in Washington DC
globenewswire.com
VALN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Stockholders to Learn More About the Investigation
accessnewswire.com
VALN
PFE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
prnewswire.com
VALN
PFE
Bronstein, Gewirtz & Grossman, LLC Encourages Valneva SE (VALN) Investors to Inquire about Securities Investigation
accessnewswire.com
VALN
PFE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Valneva SE – VALN
globenewswire.com
VALN
PFE
Pfizer et Valneva annoncent que le candidat vaccin contre la maladie de Lyme démontre une forte efficacité dans l’essai de Phase 3 VALOR
globenewswire.com
PFE
VALN
Elaris Secures Exclusive Global License from Valneva for C. difficile Vaccine Program
prnewswire.com
VALN
Valneva Reports Full Year 2025 Audited Consolidated Financial Results
globenewswire.com
VALN
Valneva to Report Full Year 2025 Consolidated Financial Results on March 18, 2026
globenewswire.com
VALN
Valneva to Participate in Upcoming Investor Conferences
globenewswire.com
VALN